Coal India OFS Attracts Rs 19000 Crore in Bids Government Exercises Greenshoe Option China Confirms Order for 200 Boeing Aircraft Emphasizing Aviation as Key Cooperation Area with US Broadcom Meta and Industry Partners Invest 125 Million in Semiconductor Research Hub at UCLA European Commissions EV Push Contradicted by Own Fleets Strasbourg Range Issue JW Therapeutics CEO China Pharma Sector Unaffected by Beijings Tech Deal Scrutiny Salesforce CEO Marc Benioff Details Turnaround Strategy Amid Stock Struggles LION Q1 2026 Earnings Strong EPS Surprise of 5296 Drives Stock Rally ICON Q4 2025 Earnings EPS Miss Highlights Operational Challenges Airship AI Holdings Inc AISP Q3 2025 Earnings EPS Misses Estimates by a Wide Margin Yet Stock Rallies OSBC Q1 2026 Earnings EPS Falls Short of Expectations as Revenue Details Remain Undisclosed NPWR Q1 2026 Earnings EPS Misses Estimates as Net Power Focuses on Commercial Deployment KLX Energy Services KLXE Declines 327 Tests Key Support Near 284 Dow Inc DOW Shows Modest Uptick as Investors Assess Chemical Sector Headwinds Akebia Therapeutics AKBA Holds Steady at 102 as Stock Consolidates Near Key Support Cheer Holding Inc CHR Surges 663 Breaking Through Resistance or Temporary Bounce Erasca Q1 2026 Earnings WiderThanExpected Loss Weighs on Shares SPFI Q1 2026 Earnings EPS Misses Estimates Stage Set for Cautious Outlook SABS Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development Shares Edge Higher Box Q1 2026 Earnings Strong EPS Beat Drives Positive Momentum INDP Q4 2025 Earnings EPS Misses Estimates as PreClinical Costs Continue Stock Declines 9 Cheetah Mobile CMCM Q4 2025 Earnings Loss Per ADS of 110 Stock Declines 35 Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Lead Morning Market News TEL Q1 2026 Earnings EPS Slightly Beats Estimates Amid Modest Stock Reaction NEN Q4 2024 Earnings Strong PerUnit Earnings Highlight Steady Real Estate Performance LUNR Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent MLM Q1 2026 Earnings Slight EPS Miss Amid Solid Aggregate Demand RNTX Q1 2026 Earnings Narrowed Loss Beats Estimates as Rein Therapeutics Advances Pipeline C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Amid Continued Pipeline Progress Autolus Therapeutics Q1 2026 Earnings EPS Miss Reflects Ongoing RD Investment BUR Q1 2026 Earnings Massive EPS Miss Sends Shares Lower